metaproterenol and Placenta Diseases
metaproterenol has been researched along with Placenta Diseases in 1 studies
Metaproterenol: A beta-2 adrenergic agonist used in the treatment of ASTHMA and BRONCHIAL SPASM.
orciprenaline : A racemate composed of equimolar amounts of (R)- and (S)-orciprenaline. Used (as its sulfate salt) to relax the airway muscles and improve breathing for patients suffering from asthma or bronchitis.
5-[1-hydroxy-2-(isopropanylamino)ethyl]benzene-1,3-diol : A member of the class of resorcinols bearing an additional 1-hydroxy-2-(isopropanylamino)ethyl substituent at position 5 of resorcinol itself.
Placenta Diseases: Pathological processes or abnormal functions of the PLACENTA.
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Janisch, H | 1 |
Leodolter, S | 1 |
Reinold, R | 1 |
Other Studies
1 other study available for metaproterenol and Placenta Diseases
Article | Year |
---|---|
[Enhancing utero-placental blood flow with EPH-gestosis patients through long-term therapy with beta-sympathomimetica (author's transl)].
Topics: Adrenergic beta-Agonists; Female; Humans; Indium; Long-Term Care; Maternal-Fetal Exchange; Metaprote | 1974 |